alexa Giridhara Rao Jayandharan
ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Giridhara Rao Jayandharan

Giridhara Rao Jayandharan Giridhara Rao Jayandharan
Centre for Stem Cell Research
Christian Medical College
Office: +91 416 307-5118
Fax: +91 416 307-4103

Prof Jayandharan Rao has received his PhD in TN MGR medical University during the period of 2006. Currently, he is working as working as an Associate Professor at the Christian Medical College, Vellore, India. During this past 8 years he has been actively involved in translational research to develop gene therapy using adeno-associated virus (AAV) vectors. Based on this research he has received several awards and honors, such as: Swarnajayanthi award from Department of Science and Technology (2011), Innovative young biotechnologist award from Department of Biotechnology (2010), Eberhard Mammen Young Investigator award (2010) and Bayer Early career investigator award from Bayer Inc USA (2010) in recognition of his expertise in gene therapy research. His work has been invited to be presented in several international events including World federation of hemophilia congress in Vancouver, Bangkok, Paris, Chicago. He is serving as an expert reviewer for journals like Molecular Therapy, J of Thrombosis Haemostasis, FEBS journal, Gene Therapy etc. He has also authored 53 research articles/books. He is a member of American Society of Gene and Cell Therapy, International society of thrombosis and hemostasis and world federation of hemophilia. He has been honoured as Invited meber in Hematology and Immunology gene and cell therapy committee, ASGCT and Lab sciences committee, World Federation of Hemophilia.

Research Interest

The collective experience with Adeno-associated virus (AAV) vector mediated human gene therapy trials so far, have clearly pointed to the need for substantial improvement in the efficiency of AAV mediated transgene expression as well as the need to attenuate the capsid-or transgene specific innate or adaptive immune responses against these vectors to achieve successful long-term gene transfer. My research is thus focused on dissecting out the basic biology of AAV life-cycle by understanding the interactions between AAV and various host cellular proteins, use this knowledge to design strategies to either augment the efficiency of gene transfer or intervene with (immune response) processes which are detrimental to AAV's survival, yet maintain the safety of these interventionist strategies to the host cellular environment and finally authenticate their use in therapeutic models such as pre-clinical animal models of haemophilia and leukemia.


Hemophilia: Disease, Diagnosis and Treatment

Giridhara Rao Jayandharan and Alok Srivastava

Review Article: J Genet Syndr Gene Ther 2013, S1-005

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version